{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:03:39Z","timestamp":1777579419254,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.micpath.2023.106092","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T22:36:26Z","timestamp":1680215786000},"page":"106092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Immunological evaluation of a recombinant vaccine delivered with an analogous hyaluronic acid chitosan nanoparticle-hydrogel against Toxoplasma gondii in mice"],"prefix":"10.1016","volume":"179","author":[{"given":"Hu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenze","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baocan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.micpath.2023.106092_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.micpath.2023.106092_bib2","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S2352-3018(17)30005-X","article-title":"Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.micpath.2023.106092_bib3","series-title":"StatPearls. Treasure Island","article-title":"Congenital toxoplasmosis","author":"Kota","year":"2021"},{"key":"10.1016\/j.micpath.2023.106092_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00037","article-title":"Toxoplasma gondii infection and toxoplasmosis in farm animals: risk factors and economic impact","volume":"15","author":"Stelzer","year":"2019","journal-title":"Food Waterborne Parasitol"},{"key":"10.1016\/j.micpath.2023.106092_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.micpath.2023.106092_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00036","article-title":"Treatment of toxoplasmosis: current options and future perspectives","volume":"15","author":"Konstantinovic","year":"2019","journal-title":"Food Waterborne Parasitol"},{"issue":"1","key":"10.1016\/j.micpath.2023.106092_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12879-020-05220-2","article-title":"Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis","volume":"20","author":"Sahar","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2023.106092_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104441","article-title":"Protective immunity induced by a DNA vaccine cocktail expressing TgSAG1, TgROP2, and the genetic adjuvant HBsAg against Toxoplasma gondii infection","volume":"147","author":"Sun","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2023.106092_bib9","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3389\/fmicb.2019.01875","article-title":"Immunization with a live-attenuated RH:DeltaNPT1 strain of toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2023.106092_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4161\/hv.21006","article-title":"Vaccines against Toxoplasma gondii: status, challenges and future directions","volume":"8","author":"Liu","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"issue":"8","key":"10.1016\/j.micpath.2023.106092_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.gt.3302213","article-title":"Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation","volume":"11","author":"Wang","year":"2004","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.micpath.2023.106092_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1097-2765(03)00113-8","article-title":"Aldolase forms a bridge between cell surface adhesins and the actin cytoskeleton in apicomplexan parasites","volume":"11","author":"Jewett","year":"2003","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.micpath.2023.106092_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsb.2015.02.008","article-title":"The apicomplexan glideosome and adhesins - structures and function","volume":"190","author":"Boucher","year":"2015","journal-title":"J. Struct. Biol."},{"issue":"12","key":"10.1016\/j.micpath.2023.106092_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003809","article-title":"Toxoplasma gondii-induced activation of EGFR prevents autophagy protein-mediated killing of the parasite","volume":"9","author":"Muniz-Feliciano","year":"2013","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.micpath.2023.106092_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002784","article-title":"The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response","volume":"8","author":"Niedelman","year":"2012","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.micpath.2023.106092_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024434","article-title":"Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it","volume":"6","author":"Virreira Winter","year":"2011","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.micpath.2023.106092_bib17","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1074\/jbc.M113.544718","article-title":"Toxoplasma gondii virulence factor ROP18 inhibits the host NF-kappaB pathway by promoting p65 degradation","volume":"289","author":"Du","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2023.106092_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/viru.3.1.18340","article-title":"Inhibition of ATF6beta-dependent host adaptive immune response by a Toxoplasma virulence factor ROP18","volume":"3","author":"Yamamoto","year":"2012","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/14712598.2018.1413086","article-title":"Moving towards improved vaccines for Toxoplasma gondii","volume":"18","author":"Li","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.micpath.2023.106092_bib20","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.2147\/IJN.S165876","article-title":"Novel application of trimethyl chitosan as an adjuvant in vaccine delivery","volume":"13","author":"Malik","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2023.106092_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fcimb.2018.00163","article-title":"Chitosan microsphere used as an effective system to deliver a linked antigenic peptides vaccine protect mice against acute and chronic toxoplasmosis","volume":"8","author":"Guo","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons","volume":"44","author":"Carroll","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.immuni.2016.03.002","article-title":"Chitosan: an adjuvant with an unanticipated STING","volume":"44","author":"Riteau","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.micpath.2023.106092_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020487","article-title":"Chitosan derivatives and their application in biomedicine","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"30","key":"10.1016\/j.micpath.2023.106092_bib25","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1039\/C6NR03256G","article-title":"Recent advances in chitosan-based nanoparticulate pulmonary drug delivery","volume":"8","author":"Islam","year":"2016","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.micpath.2023.106092_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1517\/17425247.2014.867326","article-title":"Thermosensitive chitosan\/glycerophosphate-based hydrogel and its derivatives in pharmaceutical and biomedical applications","volume":"11","author":"Supper","year":"2014","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.micpath.2023.106092_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115577","article-title":"Comparison of three water-soluble polyphosphate tripolyphosphate, phytic acid, and sodium hexametaphosphate as crosslinking agents in chitosan nanoparticle formulation","volume":"230","author":"Sang","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"1\u20133","key":"10.1016\/j.micpath.2023.106092_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.micpath.2023.106092_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00197-1","article-title":"Chitosan for mucosal vaccination","volume":"52","author":"van der Lubben","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2023.106092_bib30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2023.106092_bib31","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3389\/fimmu.2020.00935","article-title":"Immune response to Salmonella enteritidis infection in broilers immunized orally with chitosan-based Salmonella subunit nanoparticle vaccine","volume":"11","author":"Han","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2023.106092_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijbiomac.2021.01.105","article-title":"Chitosan hydrogel loaded with recombinant protein containing epitope C from HSP90 of Candida albicans induces protective immune responses against systemic candidiasis","volume":"173","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2023.106092_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vetpar.2017.02.007","article-title":"Preliminary evaluation of a thermosensitive chitosan hydrogel for Echinococcus granulosus vaccine delivery","volume":"236","author":"Umair","year":"2017","journal-title":"Vet. Parasitol."},{"issue":"7","key":"10.1016\/j.micpath.2023.106092_bib34","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biomaterials.2011.11.068","article-title":"Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization","volume":"33","author":"Wu","year":"2012","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.micpath.2023.106092_bib35","article-title":"Nanoparticle-hydrogel composites: concept, design, and applications of these promising, multi-functional materials","volume":"2","author":"Thoniyot","year":"2015","journal-title":"Adv. Sci."},{"issue":"14","key":"10.1016\/j.micpath.2023.106092_bib36","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1016\/j.biomaterials.2010.01.139","article-title":"A chitosan\/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.micpath.2023.106092_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhazmat.2014.05.079","article-title":"Chitosan\/tripolyphosphate nanoparticles loaded with paraquat herbicide: an environmentally safer alternative for weed control","volume":"278","author":"Grillo","year":"2014","journal-title":"J. Hazard Mater."},{"key":"10.1016\/j.micpath.2023.106092_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.actbio.2019.04.023","article-title":"Thermally triggered injectable chitosan\/silk fibroin\/bioactive glass nanoparticle hydrogels for in-situ bone formation in rat calvarial bone defects","volume":"91","author":"Wu","year":"2019","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jconrel.2006.11.024","article-title":"Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization","volume":"117","author":"Liu","year":"2007","journal-title":"J. Contr. Release"},{"issue":"Suppl","key":"10.1016\/j.micpath.2023.106092_bib40","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1017\/S003118200000144X","article-title":"A commercial vaccine for ovine toxoplasmosis","volume":"110","author":"Buxton","year":"1995","journal-title":"Parasitology"},{"issue":"5","key":"10.1016\/j.micpath.2023.106092_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/vr.129.5.89","article-title":"Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant","volume":"129","author":"Buxton","year":"1991","journal-title":"Vet. Rec."},{"issue":"5","key":"10.1016\/j.micpath.2023.106092_bib42","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1128\/IAI.02756-14","article-title":"Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection","volume":"83","author":"Fox","year":"2015","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.micpath.2023.106092_bib43","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/1751-7915.13668","article-title":"Toxoplasma gondii alpha-amylase deletion mutant is a promising vaccine against acute and chronic toxoplasmosis","volume":"13","author":"Yang","year":"2020","journal-title":"Microb. Biotechnol."},{"issue":"47","key":"10.1016\/j.micpath.2023.106092_bib44","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.vaccine.2009.08.043","article-title":"Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice","volume":"27","author":"Peng","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2023.106092_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00430-016-0483-9","article-title":"Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route","volume":"206","author":"Rashid","year":"2017","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2023.106092_bib46","first-page":"1","article-title":"Immunological protection of MIC1-MIC6-rop18 recombinant vaccine against toxoplasma gondii in mice","author":"Li","year":"2022","journal-title":"Chinese Journal of Animal Infectious Diseases"},{"key":"10.1016\/j.micpath.2023.106092_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111081","article-title":"Biomolecular uptake effects on chitosan\/tripolyphosphate micro- and nanoparticle stability","volume":"193","author":"Cai","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.micpath.2023.106092_bib48","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.1208\/pt0804098","article-title":"Designing chitosan-dextran sulfate nanoparticles using charge ratios","volume":"8","author":"Chen","year":"2007","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib49","first-page":"165","article-title":"Chitosan-based nanoparticles in mucosal vaccine delivery","volume":"73","author":"Mehrabi","year":"2018","journal-title":"Arch Razi Inst"},{"issue":"7","key":"10.1016\/j.micpath.2023.106092_bib50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0142-9612(96)00167-6","article-title":"In vitro and in vivo degradation of films of chitin and its deacetylated derivatives","volume":"18","author":"Tomihata","year":"1997","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.micpath.2023.106092_bib51","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jbm.a.32923","article-title":"Injectable chitosan-based hydrogel for implantable drug delivery: body response and induced variations of structure and composition","volume":"95","author":"Sun","year":"2010","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.micpath.2023.106092_bib52","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fimmu.2017.00730","article-title":"Immunization with toxoplasma gondii GRA17 deletion mutant induces partial protection and survival in challenged mice","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2023.106092_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijbiomac.2020.03.065","article-title":"Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): the potential immune adjuvants and nano carriers","volume":"154","author":"Zhao","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib54","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejpb.2012.03.021","article-title":"Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery","volume":"81","author":"Wu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2023.106092_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2016.09.082","article-title":"Improving adjuvanticity of quaternized chitosan-based microgels for H5N1 split vaccine by tailoring the particle properties to achieve antigen dose sparing effect","volume":"515","author":"Wang","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"27","key":"10.1016\/j.micpath.2023.106092_bib56","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.vaccine.2009.03.040","article-title":"Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1\/Th2 bias in the immune response and protection against infection","volume":"27","author":"Mann","year":"2009","journal-title":"Vaccine"},{"issue":"Pt A","key":"10.1016\/j.micpath.2023.106092_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2015.09.069","article-title":"Shape and size-dependent immune response to antigen-carrying nanoparticles","volume":"220","author":"Kumar","year":"2015","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.micpath.2023.106092_bib58","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"issue":"11","key":"10.1016\/j.micpath.2023.106092_bib59","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL-4 directs the development of Th2-like helper effectors","volume":"145","author":"Swain","year":"1990","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2023.106092_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0171-2985(99)80064-3","article-title":"Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function","volume":"201","author":"Yap","year":"1999","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.micpath.2023.106092_bib61","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/IAI.67.5.2233-2240.1999","article-title":"Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK\/STAT pathway","volume":"67","author":"Ceravolo","year":"1999","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib62","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/cells1030396","article-title":"LC3-Associated phagocytosis (LAP): connections with host autophagy","volume":"1","author":"Lai","year":"2012","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.micpath.2023.106092_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01157-15","article-title":"A noncanonical autophagy pathway restricts toxoplasma gondii growth in a strain-specific manner in IFN-gamma-Activated human cells","volume":"6","author":"Selleck","year":"2015","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib64","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells","volume":"178","author":"D'Andrea","year":"1993","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.micpath.2023.106092_bib65","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.172.3.921","article-title":"Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells","volume":"172","author":"Le Gros","year":"1990","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.micpath.2023.106092_bib66","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.4049\/jimmunol.148.11.3578","article-title":"IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity","volume":"148","author":"Oswald","year":"1992","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2023.106092_bib67","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","article-title":"In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha","volume":"157","author":"Gazzinelli","year":"1996","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.micpath.2023.106092_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143087","article-title":"Vaccination with recombinant microneme proteins confers protection against experimental toxoplasmosis in mice","volume":"10","author":"Pinzan","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.micpath.2023.106092_bib69","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-3024.2007.00982.x","article-title":"Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host","volume":"29","author":"Correa","year":"2007","journal-title":"Parasite Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2023.106092_bib70","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase","volume":"164","author":"Kang","year":"2000","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.micpath.2023.106092_bib71","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00436-015-4701-y","article-title":"Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins","volume":"114","author":"Grzybowski","year":"2015","journal-title":"Parasitol. Res."},{"issue":"4","key":"10.1016\/j.micpath.2023.106092_bib72","first-page":"711","article-title":"Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides","volume":"27","author":"Araujo","year":"1974","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2023.106092_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.exppara.2016.04.003","article-title":"Toxoplasma gondii: protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB\/c mice","volume":"166","author":"Gong","year":"2016","journal-title":"Exp. Parasitol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:31:31Z","timestamp":1736404291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401023001250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":73,"alternative-id":["S0882401023001250"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106092","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological evaluation of a recombinant vaccine delivered with an analogous hyaluronic acid chitosan nanoparticle-hydrogel against Toxoplasma gondii in mice","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106092"}}